United Arab Emirates: As the heat continues to rise in the UAE, Zulekha Hospital has introduced the latest treatments to combat excessive sweating (Osmidrosis) in the armpits which results in staining of clothing and causes bad odour, which is often brought by soaring temperatures and other scenarios. Recent global research shows that 85% of excessive sweating patients wait 3+ years to discuss their problem with a healthcare professional, and 50% of patients wait over 10 years to do so*.
Sweating is a normal physiological process which is crucial for body heat regulation. The basic pathology of excessive sweating is an abnormal increase in the number of sweat producing glands. In Osmidrosis surgery, a very thin layer of the under surface of skin is removed using special instruments, thereby removing the excessive sweat glands. The surgery targets only a specific area (axilla) as a part of the treatment, the rest of the body parts continue to sweat normally. The procedure is safe and straight forward and the recurrence of the condition is seen in as little as 10% of patients.
“Excessive sweating affects both sexes and all ages, it is a common problem and no-one should feel ashamed if they are suffering from it. Living in climate where temperatures are high, the issue is more prominent than in other parts of the world. The simple Osmidrosis procedure is able to relieve patients of any anxiety they may feel in relation to excessive sweating so that they can go about their daily lives worry free,” said Dr. Chandra Bose, Consultant Plastic Surgeon at Zulekha Hospital.
The Osmidrosis procedure is usually a one-time procedure as an outpatient surgery where patients are discharged the same day. Very rarely the patient might have to undergo a second sitting if the symptoms persist. Post-surgery, there is no special precautions needed after the procedure, the patient will have a padded dressing in the operated area for five days, which will removed on the sixth day. The patient will be advised to wash the area with soap and warm water twice a day.
For patients suffering from excessive sweating of palms and feet, the plastic surgery department offers Botox injection treatment, which would give significant relief that lasts for more than six months.
Osmidrosis surgery is also advocated in early stages of Hidradenitis Supporitiva, a condition characterised by recurrent and relapsing abscesses or pus pointing swellings resulting from an abnormal increase in the number of oil producing glands in the skin. The condition, if treated early, can be very helpful to patients affected by it, who would otherwise have to take multiple courses of antibiotics and multiple painful pus draining procedures.
Managing Director of Zulekha Healthcare Group Mr. Taher Shams says, “By way of introducing the latest plastic surgeries and global expertise in our facilities in Dubai, we have ensured accessibility to the best of the reconstructive and cosmetic surgeries right here in the UAE. Alongside quality care, authentic treatments are assured.”
The Osmidrosis procedure is a part of the hospital’s plastic surgery portfolio. The plastic surgery spectrum has been growing in Zulekha Hospital embracing a wide portfolio which includes aesthetic plastic surgery, reconstructive plastic surgery for trauma and oncology, pediatric plastic surgery (reconstruction of various congenital deformities), genito-urologic surgery (female genital rejuvenation) and burn care.
*Source: International Hyperhidrosis Society
About Zulekha Healthcare Group
The Zulekha Hospital brand is part of the Zulekha Healthcare Group, and is among the forerunners in UAE healthcare for 25 years now.
Today the Zulekha Healthcare group includes three multidisciplinary hospitals with two in the UAE in Dubai and Sharjah, and the third in Nagpur, India. The Group also has four UAE medical centres and three pharmacies providing specialised treatments in over 30 disciplines.
Zulekha Hospital has received extensive recognition for its commitment towards quality care and sustainable business practices, such as Dubai Quality Appreciation Award, Dubai Quality Award, Mohammed Bin Rashid Al Maktoum Business Excellence Award, underling a commitment to providing high quality healthcare to patients and society at large.
For more information please visit: www.zulekhahospitals.com© Press Release 2018
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.